首页 | 本学科首页   官方微博 | 高级检索  
检索        

IRS2基因G1057D变异与中国汉族人肥胖型2型糖尿病的相关性
引用本文:孔令芳,赵彦艳,李强,郑晓敏,丁茜,刘洪,刘国良.IRS2基因G1057D变异与中国汉族人肥胖型2型糖尿病的相关性[J].中华医学遗传学杂志,2005,22(4):387-390.
作者姓名:孔令芳  赵彦艳  李强  郑晓敏  丁茜  刘洪  刘国良
作者单位:1. 110001,沈阳,中国医科大学附属第一医院内分泌科
2. 110001,沈阳,中国医科大学附属第一医院医学遗传教研室
基金项目:辽宁省科技厅重点科技攻关基金(2001225001-16)
摘    要:目的 研究IRS2基因G1057D突变与中国汉族人2型糖尿病(type 2 diabetes mellitus,T2DM)的相关性。方法 选取辽宁汉族人T2DM组218例,健康对照组221名,各分为肥胖和非肥胖两个亚组。应用聚合酶链反应-限制性片段长度多态性方法筛查IRS2 G1057D突变并探讨与T2DM的相关性。结果 (1)IRS2 G1057D总突变频率为29%。非肥胖DM组DD型频率显著低于非肥胖对照组,Logistic回归分析显示DD型OR值为0.265;而肥胖DM组DD型频率则显著高于肥胖对照组,Logistic回归分析显示DD型的OR值为3.991。(2)在非肥胖亚组:DM组DD型的WHR高于同组GG型(P〈0.01);对照组DD型的FPG及2hCP低于同组GG型(P〈0.05,P〈0.01),HOMA-B高于同组GG型(P〈0.01)。在肥胖亚组:DM组DD型的WHR、HOMA-IR及2hPG、2hINS、2hCP均高于同组GG型,HOMA-B低于同组GG型;对照组DD型的WHR、2hINS、HOMA-IR及HOMA-B也分别高于及低于同组GG型(均P〈0.05)。结论 IRS2基因G1057D突变以肥胖为中介与他DM相关联。

关 键 词:IRS2基因  G1057D变异  中国  汉族  肥胖型2型糖尿病
修稿时间:2004年9月8日

Study on the relationship between G1057D variants of IRS2 gene and obese T2DM in Chinese Han subjects
KONG Ling-fang,ZHAO Yan-yan,LI Qiang,ZHENG Xiao-min,DING Qian,LIU Hong,LIU Guo-liang.Study on the relationship between G1057D variants of IRS2 gene and obese T2DM in Chinese Han subjects[J].Chinese Journal of Medical Genetics,2005,22(4):387-390.
Authors:KONG Ling-fang  ZHAO Yan-yan  LI Qiang  ZHENG Xiao-min  DING Qian  LIU Hong  LIU Guo-liang
Institution:Department of Endocrinology, the First Affiliated Hospital, China Medical University, Shenyang, Liaoning, 110001 PR China.
Abstract:OBJECTIVE: To investigate the relationship between the G1057D variants of insulin receptor substrate-2(IRS2) gene and type 2 diabetes mellitus (T2DM) in subjects. METHODS: Four hundred and thirty-nine Chinese Han subjects, including 218 patients with T2DM and 221 normal controls, were selected from the Hans in the Liaoning area, and each group was divided into two subgroups according to body mass index. The G1057D variants of IRS2 were detected by polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP) and their relationships with T2DM were analyzed. RESULTS: (1) The frequency of G1057D variant was 29% in all subjects. The frequency of DD genotype was significantly lower in non-obese DM group than in non-obese control group. The Logistic regression analysis showed that the odds ratio of DD genotype was 0.265. The frequency of DD genotype was significantly higher in obese DM group than in obese control group. The Logistic regression analysis showed that the odds ratio of DD genotype was 3.991. (2) In the non-obese control group, the FPG and 2hCP of DD genotypes were lower than those of GG genotypes (P< 0.05, P< 0.01), the HOMA-B of DD genotypes was higher than that of GG genotype (P< 0.01). In the non-obese DM group, the waistline/hip ratio (WHR) of DD genotypes was higher than that of GG genotypes(P< 0.01). In the obese DM group, the WHR, HOMA-IR, 2hPG, 2hINS and 2hCP levels of DD genotypes were higher than those of GG genotypes, while the level of HOMA-B of DD genotypes was lower than that of GG genotypes. In the obese control group, the WHR, HOMA-IR, 2hPG, 2hINS and 2hCP levels of DD genotype were higher than those of GG genotype, and the HOMA-B level of DD genotype was lower than that of GG genotypes (P< 0.05). CONCLUSION: The relationships between G1057D variants of IRS2 and T2DM are mediated by obesity.
Keywords:insulin receptor substrate 2 gene  type 2 diabetes mellitus  obesity  insulin resistance
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号